Status:
UNKNOWN
The Phonak EduLink-System in Students With Specific Performance Deficits in Speech-in-Noise Intelligibility
Lead Sponsor:
University Hospital Muenster
Collaborating Sponsors:
Phonak AG, Switzerland
Conditions:
Auditory Processing Disorder
Eligibility:
All Genders
6-11 years
Phase:
NA
Brief Summary
In the management and remediation of students with specific performance deficits in speech-in-noise intelligibility, most often, a "triad" approach for treatment is used, which includes direct therapy...
Eligibility Criteria
Inclusion
- Diagnosis of specific performance deficits in speech-in-noise intelligibility based on two or more standardized tests of auditory processing in noise including retests.
- Students in the 1st to 4th class of primary school
Exclusion
- Hearing loss, defined as:
- Air conduction pure tone thresholds (250-8000 Hz) exceeding 20 dBHL
- Air-bone gaps, even in the presence of normal sensitivity, exceeding 10 dBHL
- Abnormal tympanogram
- History or diagnosis of behavioral and/or emotional disorders meeting ICD-GM-criteria (including attention deficit/hyperactivity disorders (AD-/HD)
- Non-German speaking
- Cognitively impaired children (IQ \< 85)
- Children currently using psychoactive medication
- Students with special education
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00167128
Start Date
March 1 2005
Last Update
August 15 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Phoniatrics and Pediatric Audiology, University Hospital Münster
Münster, Germany, 48149
2
Phonak AG
Stäfa, Switzerland, 8712